Gilead Sciences, Inc. (BVMF:GILD34)
Brazil · Delayed Price · Currency is BRL 327.04
+13.84 (4.42%)
At close: Nov 12, 2025
Gilead Sciences Market Cap
Gilead Sciences has a market cap or net worth of 810.79 billion as of November 13, 2025. Its market cap has increased by 28.48% in one year.
Market Cap
810.79B
Enterprise Value
886.84B
Revenue
155.02B
Ranking
n/a
PE Ratio
18.76
Stock Price
327.04
Market Cap Chart
Since January 22, 1992, Gilead Sciences's market cap has increased from 240.84M to 810.79B, an increase of 336,549.53%. That is a compound annual growth rate of 27.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2025 | 810.79B | 13.88% |
| Dec 31, 2024 | 711.99B | 45.36% |
| Dec 29, 2023 | 489.80B | -13.96% |
| Dec 30, 2022 | 569.24B | 12.17% |
| Dec 31, 2021 | 507.47B | 33.81% |
| Dec 31, 2020 | 379.26B | 14.77% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rede D'Or São Luiz | 101.14B |
| Raia Drogasil | 39.23B |
| Hypera | 16.31B |
| Fleury | 8.62B |
| Odontoprev | 6.72B |
| Empreendimentos Pague Menos | 2.94B |
| Diagnósticos da América | 2.56B |
| Blau Farmacêutica | 2.26B |